<DOC>
	<DOC>NCT02477033</DOC>
	<brief_summary>During this project the safety, tolerability and effect on gut microbiota of oral administration of Butyricicoccus pullicaecorum was investigated in healthy human volunteers by a placebo-controlled cross-over randomized study.</brief_summary>
	<brief_title>Impact of Butyricicoccus Pullicaecorum in Healthy Subjects</brief_title>
	<detailed_description>Intervention periods were 4 weeks, with daily intake of 1 capsule. Wash-out periods were 3 weeks.</detailed_description>
	<criteria>BMI between 18 and 28 kg/mÂ² Good general health Regular eating pattern (3 meals/day on at least 5 days/week) Chronic gastrointestinal disease (Crohn's disease, ulcerative colitis, irritable bowel syndrome, chronic constipation or chronic diarrhea) Surgery of the gastrointestinal tract (except for an appendectomy) Use of antibiotics during the month preceding the study Use of medication or dietary supplements influencing gut transit or intestinal microbiota during the month preceding the study. Examples of such medication/dietary supplements are antispasmodics (e.g. buscopan), antidiarrheal medication (e.g. imodium), probiotic medication (e.g. lacteol, enterol) Intake of pre or probiotics during the study or during the month preceding the study Being on a weightloss diet during the study or during the month preceding the study Extreme dietary habits (e.g. vegan, Atkins diet, Montignac diet) Females who are pregnant, lactating or planning to become pregnant during the study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>